MedPath

HP Improves Sleep and Overall Survival Rate in Maintenance Hemodialysis Patients

Not Applicable
Completed
Conditions
Hemoperfusion
Registration Number
NCT03487146
Lead Sponsor
Shanghai Pudong Hospital
Brief Summary

Sleep disturbance has been long-standing torments in most of patients with maintenance hemodialysis (HD). In this study, we attempted to explore whether long-term hemoperfusion (HP) could improve sleep disorder and increase overall survival rate in HD patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
156
Inclusion Criteria
  1. duration of maintenance HD should be equal or more than 3 months,
  2. patient's age should be equal or more than 18 years
Exclusion Criteria
  • i) he/she diagnosed with malignant tumors, an active rheumatism, infectious diseases, or a severe heart failure ii) he/she would disagree with the study
  1. he/she has received a short-term poor prognosis
  2. he/she would be more than 80 years old

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
improvement of self-reported sleep disturbance2 years

Analysis of the sleep disturbance by using Pittsburgh Sleep Quality Index (PSQI) questionnaire

Secondary Outcome Measures
NameTimeMethod
survival2 years

increase overall survival rate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HP Improves Sleep and Overall Survival Rate in Maintenance Hemodialysis Patients | MedPath